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Kidney Disease in Brucellosis
Shokoufeh Savaj
Abstract
Brucellosis, a prevalent zoonosis disease in different countries, can involve the 
kidney during infection and also present in the complicated form in hemodialysis 
(HD), peritoneal dialysis (PD), and kidney transplant (Tx) patient. In spite of few 
reports of kidney involvements in the literature, this infection can imitate a wide 
range of glomerular disease from minimal change, membranous glomeropathy, 
focal and diffuse proliferative glomerular disease to rapidly progressive glomerulo-
nephritis. Cryoglobulinemia, thrombotic microangiopathy, and ANCA-associated 
glomerular disease are vasculitis form of the disease. Tubulointerstitial involve-
ment, electrolyte disorder, renal abscess, and pyelonephritis can present the same 
as other Gram-negative infections. Moreover, peritonitis in PD patient, spondylo-
arthropathy in HD, and severe infection in kidney Tx patients have been reported. 
Infection recurrence and infection from kidney donors are another dilemma in 
renal recipients. Brucellosis as a multifaced disease can mimic a wide range of 
presentations in nephrology. Clinicians should keep in mind the diverse pictures of 
the disease, especially when they practice in the endemic area.
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1. Introduction
Brucellosis, a prevalent zoonosis disease with a worldwide distribution, can involve 
the kidney during infection. In 1889, Bruce [1] firstly reported kidney disease in Malt 
fever. Since then, a wide range of kidney involvements from direct invasion of Brucella 
with abscess and tubulointerstitial nephritis, immune complex disease, vasculitis, and 
drug toxicity have been reported. Brucella infection in immunocompromised patient 
can induce a confusing picture with peritonitis in peritoneal dialysis (PD), spondy-
lodiscitis in hemodialysis, and complicated form of the disease in kidney transplant 
(TX) patients. Immunosuppressive monitoring, drug side effects, and donor to recipi-
ent transmission or recurrence are great challenges in the management of organ recipi-
ents with brucellosis. In this chapter, different presentations of brucellosis in kidney 
including glomeruli, tubulointerstitial, and vasculature involvement are discussed. 
Secondly, the Brucella infection in PD, HD, and Tx patients are reviewed, and finally, 
the chance of infection transmission of Brucellosis in the donor and recipients and the 
challenging point of pretransplant evaluation in donors and recipients are discussed.
2. Glomerular disease in brucellosis
Glomerular disease is an uncommon presentation in brucellosis. It can present 
with hematuria, pyuria, proteinuria, increased blood pressure, edema, and renal 
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failure. Glomerular involvement from mild proteinuria, microscopic hematuria up to 
the severe presentations of glomerular disease including rapidly progressive glomeru-
litis resulted in end-stage kidney disease have been reported. Glomeruli affected by 
immune complexes or vasculitis during Brucella endocarditis. The usual glomeru-
lopathy in cases with endocarditis is focal and diffuse proliferative glomerulonephri-
tis which are presented in the literature as membranoproliferative [2] and rapidly 
progressive glomerulonephritis; IgA nephropathy reported in two patients [3, 4] 
with proteinuria and hematuria. Siegelmann et al. [4] reported a case with nephrotic 
range proteinuria (6.0–13.0 g/day) and focal and segmental glomerulonephritis with 
mesangial proliferation and heavy deposit of IgA. Proteinuria persisted 3 months 
after completion of therapy, which indicates a secondary form of IgA nephropathy. 
Minimal change disease is a rare presentation of brucellosis reported only in one case 
without endocarditis. The patient had massive proteinuria who received prednisolone 
and antimicrobial treatment with complete remission and no recurrence after 1 year 
[5]. Membranous nephropathy is also diagnosed in one case with proteinuria [6].
3. Vasculitis in brucellosis
Vasculitis is a lethal picture of brucellosis with systemic organ involvement. 
Turgay et al. [7] reported 52-year-old male with Brucella infection and ANCA-
associated vasculitis that induced rapidly progressive glomerulitis. The patient had 
endocarditis with vegetation on the aortic valve and leukocytoclastic vasculitis. 
Serology showed a high titer of serum agglutinin for Brucella and positive P-ANCA 
test. The patient recovered with combination therapy of plasmapheresis, meth-
ylprednisolone pulse, and antibiotic therapy. The other vasculitis form of kidney 
disease is cryoglobulinemia. This systemic disease can happen in malignancy, 
autoimmune, and infectious disease. Mixed cryoglobulinemia in brucellosis has 
been reported in five cases (four from Peru and one from Spain). They had a high 
polyclonal cryoglobulin level (IgG, IgA, and IgM) with a female preponderance 
(4:1). Four cases had positive bone marrow culture and one diagnosed based on 
serology [8]. Thrombotic microangiopathy that presents with microangiopathic 
hemolytic anemia, thrombocytopenia, and variable signs of organ impairment due 
to platelet aggregation in the microcirculation has been reported in patients with 
brucellosis. Erdem et al. [9] reported a 51-year-old man with thrombotic micro-
angiopathy, hematuria, diminished consciousness, and renal failure. The patient 
received combination therapy with antimicrobials and plasma exchange with a good 
response and no recurrence in 1.5 years follow-up.
4. Tubulointerstitial and parenchymal involvement in brucellosis
Direct invasion of parenchyma and abscess formation is a rare manifestation 
of Brucella, which has been reported in five cases in the literature. Li et al. [10] 
reported a 45-year-old man with fever and flank pain. CT scan showed a low-density 
lesion in the right kidney in CT scan and positive culture for Brucella. He received 
8 weeks course of treatment and relapse after discontinuation of treatment, which 
needed another 16 weeks course of rifampin and moxifloxacin for the eradication of 
bacteria. There are reports of acute interstitial nephritis [11] and pyelonephritis [12] 
after Brucella infection. A perplexing point is antimicrobial therapy with rifampin, 
which can induce interstitial nephritis. Salih et al. reported a 52-year-old man with a 
diagnosis of Brucella. Patient referred with acute renal failure 2 weeks after treat-
ment with rifampin. Renal failure recovered since the drug was discontinued [13].
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5. Electrolyte abnormality in Brucella infection
Syndrome of inappropriate secretion of ADH (SIADH), which presented with 
hyponatremia in a euvolemic patient without other electrolyte abnormality has 
been reported in patients with brucellosis. Bala et al. [14] in a study of 160 chil-
dren and adolescent with SIADH reported 21.9% prevalence of SIADH. Urinary 
sodium (>25 mmol/L) with normal dietary salt intake, low uric acid (<2 mg/dL), 
the absence of kidney, thyroid or adrenal disease, and history of diuretic use were 
the criteria for diagnosis. Hyponatremia had a correlation to the severity of disease 
and managed with fluid restriction. Renal tubular disorder presented in 31 patients 
with active brucellosis [15]. They had phosphorus, potassium, and sodium handling 
abnormality in 31 patients. These patients were not malnourished, received fluid 
therapy, or hospitalized. They proposed that besides glomerular damage, tubular 
dysfunction is another presentation of Brucella infection.
6. Brucellosis in hemodialysis patients
Musculoskeletal problem is a prevalent feature in hemodialysis (HD) patients, 
which presents due to renal osteodystrophy and amyloidosis resulted from beta 2 
microglobulin deposition in the joints. These symptoms can mislead the clinician to 
overlook Brucella diagnosis. Inversely, fever as a common presentation of the infectious 
disease is missing in those ill patients. Most of the reported cases of brucellosis in HD 
patients presented with musculoskeletal pain, arthralgia, low back pain, and malaise in 
the acute form of brucellosis. Paravertebral and epidural abscess with spondylodiscitis 
in thoracic and lumbar vertebra and neurobrucellosis with a headache, diplopia, and 
cranial nerve involvement were reported as the complicated chronic form brucellosis 
in HD patients [16]. There is also a report of fatal septicemia and endocarditis [17, 18] 
in HD patients. Blood cultures should be performed in HD patients when typical 
symptoms of brucellosis exist even when the patient has no fever. Drug toxicity and 
dose adjustment are the other obstacles in the treatment of these patients. Rifampin 
and doxycycline with a hepatic metabolism do not need any dose adjustment; however, 
aminoglycosides, cephalosporins, and fluoroquinolones should be prescribed based on 
patient’s eGFR and patient needs a supplement dose after dialysis course.
7. Brucellosis in peritoneal dialysis (PD) patients
Peritoneal dialysis patients are at risk of peritonitis. Gram-positive organisms 
are the common cause of infections in 80% of the episodes. There are few reports of 
peritonitis due to Brucella infection in the literature. All of the cases presented with 
a typical peritoneal infection with neutrophil predominance with a positive culture 
in 5−21 days [19]. Organ involvement is hematogenous in most of the studies; 
however, Osizik et al. [20] showed a positive peritoneal fluid culture with a negative 
blood culture and serology. They proposed a direct inoculation of bacteria from the 
catheter to peritoneum based on the patient’s occupation. The other issue in Brucella 
peritonitis in PD patients is any need for catheter removal after Brucella infection. 
Taskapan et al. [21] and Alothman et al. [22] reported two cases with a recurrence 
of infection in 6−8 weeks after treatment that resulted in catheter removal for 
complete eradication of bacteria. On the other hand, Unal et al. [23] and Solak et al. 
[19] in two different reports showed the complete cure of infection despite keeping 
peritoneal catheter. Drug regimen in these studies was 6 weeks course of rifampin 
and doxycycline.
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8. Brucellosis in renal transplant recipients
However, the prevalence of brucellosis is around 1 in 500,000 population, and 
there are few reports in renal transplant recipients. In another view, these patients 
are at risk of different opportunistic infections. Most of the time, diagnosis of 
brucellosis was lately with the complicated form of the disease. There were two 
reports of neurobrucellosis in renal Tx patients in the literature, one with loss 
of consciousness and encephalitis [24] and the other one with a seizure and 
headache [25]. Endocarditis [26], pulmonary involvement [27], hepatobiliary 
and hematologic [28], pyelonephritis and dysuria [29], and arthritis [30] were 
other presentations of the disease. They were diagnosed based on serology or 
fluid culture that finally guided to the diagnosis of brucellosis. In addition to the 
complicated form of the disease and late diagnosis, drug interferences, especially 
calcineurin inhibitors, are another challenging point in the treatment of disease. 
Rifampin decreases drug level and inversely clarithromycin increases drug level 
that induces calcineurin toxicity. Hence, streptomycin with nephrotoxic nature 
cannot be the first choice in renal Tx patient. Ting et al. suggested tigecycline as 
an alternative drug in renal Tx patient. Triple antibacterial treatment has expe-
rienced in these immunocompromised patients with a complicated form of the 
disease [26, 30]. In these six reports, all of the patients completed the 6−12 weeks 
course of treatment with a good outcome and no recurrence; however, they 
experienced a serum creatinine rise.
9. Kidney donor evaluation before transplant
Evaluation for Brucella infection is suggested before organ transplantation 
in donors and recipients, especially in endemic areas. There are some reports of 
Brucella transmission and recurrence after liver [31], bone marrow transplantation 
[32, 33]. Serologic tests including serum agglutination and ELISA should be per-
formed before organ transplant. Positive titers consisted of 1:80 in the non-endemic 
area and 1:160 in the endemic area are suspicious and needs further evaluation. 
Serologic tests are not enough to distinguish active and past infection, which needs 
more evaluation by infectious disease specialist.
10. Conclusion
In this chapter, a wide range of Brucella presentations was discussed. 
Brucellosis as a multifaced disease can imitate a large group of non-infectious 
causes of kidney disease. Hence, the misdiagnosis could be hazardous and end to 
the patient’s morbidity and mortality. Clinicians should keep in mind the diverse 
pictures of the disease, especially when they practice in the endemic area.
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